Keyphrases
Prognostic Biomarker
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Squamous Cell Carcinoma (SqCC)
100%
Tumor
62%
Human Papillomavirus Negative
37%
P16INK4a
37%
Human Papillomavirus Testing
25%
Vaginal Squamous Cell Carcinoma
25%
Multivariate Analysis
12%
Immunohistochemistry
12%
Risk Reduction
12%
Mortality Risk
12%
Genotype
12%
Early Humans
12%
Immunostaining
12%
Neoplasms
12%
Overall Survival
12%
Risk of Progression
12%
HPV16
12%
Log-rank Test
12%
Papillomavirus Infections
12%
Disease-free Survival
12%
Cox Proportional Hazards Model
12%
Prognostic Significance
12%
Patient-independent
12%
Kaplan-Meier Analysis
12%
Better Prognosis
12%
FIGO Stage
12%
Independent Pathway
12%
Human Papillomavirus DNA
12%
FIGO Stage I
12%
Routine Pathology
12%
Medicine and Dentistry
Biological Marker
100%
Wart Virus
100%
Squamous Cell Carcinoma
100%
Neoplasm
42%
P16
21%
Immunohistochemistry
14%
Multivariate Analysis
7%
Overall Survival
7%
Proportional Hazards Model
7%
Human Papillomavirus Type 16
7%
Log Rank Test
7%
Kaplan Meier Method
7%
Papillomavirus Infection
7%
Disease Free Survival
7%
Biochemistry, Genetics and Molecular Biology
Wart Virus
100%
P16
20%
Genotyping
6%
Immunostaining
6%
Independent Pathway
6%
Multivariate Analysis
6%
Overall Survival
6%
Disease Free Survival
6%
Human Papillomavirus Type 16
6%